$HIPH -Acquired license for Worthy via its subsidiary GENTS

New Post Public Reply Private Reply Replies (0) Message Board
stockstein
148
$HIPH -Acquired license for Worthy via its subsidiary GENTS www.gentsco.com ! GENTS has added significant revenue to $HIPH & is sold in Bloomingdale's, Saks, Nordstrom & all 83 Soul Cycle locations. Nice research out by See ThruEquity www.seethruequity.com/news/ a few days ago.


NEW YORK, NY / ACCESSWIRE / June 21, 2018 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has initiated coverage on American Premium Water Corp. (OTC PINK: HIPH) with a Target Price of $0.15.

The report is available here: June 2018 Initiation Report.

We initiate coverage on American Premium Water Corp. (OTC PINK: HIPH, $0.020) with a price target of $0.15. HIPH is a diversified company focused on premium consumer brands and products. It currently sells and markets hydrogen-infused water under the LALPINATM brand and luxury apparel under the Gents brand. We expect HIPH growth to be supported by two commercial initiatives planned for this year: Hydrogen-infused Water and Hydrogen CBD-infused Water. Both product lines have high potential given: 1) the rising consumer interest in legal CBD products; and 2) the large and expanding market for functional water. LALPINATM Hydrogen is already selling via select channels, and the company is planning for a full-scale launch in the coming quarters. The company debuted LALPINATM Hydrogen CBD in January 2018, and it is expected to be launched in June 2018. The functional bottled water market in the US is expected to reach ~$2.9 billion by 2020 driven by a shift in consumer preference from soda-based to more nutritional and healthier drinks. This is evident from the rising demand of seltzer water, ionized water and smart water, among others. Hydrogen-infused water has the potential to become a new category in this trend. HIPH has an early mover advantage in the hydrogen infused water market which currently has limited competition.

LALPINA Hydrogen CBD positions the company to tap into growing consumer interest around CBD related products as this is the only known Hydrogen CBD water in the market. There is a large market opportunity given the growing number of cannabis dispensaries which could be potential customers.

We are also intrigued by management's effort to position Gents as an emerging luxury apparel brand. The recent acquisition of Worthy, a JV with China-based Zhangjiagang Advanced Company (ZAC), and collaborations with Showtime and SoulCycle should help expand footprint and consumer reach. HIPH has also entered the fast growing blockchain space via the acquisition of FashionCoinX, which further diversifies its potential revenue streams. HIPH noted a number of acquisition opportunities in the pipeline - all of which could further support growth. Going forward, we expect HIPH to increase revenues and earnings via new product launches, aggressive distribution and marketing, entry into new regions and M&A.

Well positioned as a luxury consumer lifestyle brand

HIPH manufactures and distributes consumer products under the LALPINATM and Gents brands. The LALPINATM brand focuses on hydrogen infused bottled water via its two products: LALPINATM Hydrogen (launched in 1Q18) and LALPINATM Hydrogen CBD (to be launched in June 2018). The bottled water market with functional benefits such as added alkalinity, electrolytes, vitamins, minerals is seeing significant traction among consumers. The shift in consumer preference to healthier and nutritional drinks is likely to further drive the growth of functional water market. The functional bottled water market in the US is expected to reach ~$2.9 billion by 2020. HIPH has an early mover advantage in the hydrogen infused water market which currently has limited competition. LALPINATM Hydrogen CBD is a front runner in the space as the only known hydrogen infused CBD beverage available on the market. The primary competitive advantage is that it improves bioavailability of CBD and absorption. The CBD market could reach $2.1 billion by 2020, according to Hemp Business Journal.

Gents is a producer of luxury hats and other fine accessories and apparel. Presence in 200 retail outlets internationally including upscale names such as Bloomingdale's, Nordstrom, and Saks Fifth Avenue strengthens its positions as a luxury brand. The acquisition of New York-based streetwear brand, Worthy further diversifies the apparel revenue stream. It will expand the price points offered by Gents and opens up many new distribution channels.

Expansion in blockchain/crypto space

The recent acquisition of FashionCoinX marks HIPH's entry in the fast growing blockchain/crypto space. Blockchain is one of the fastest growing technologies and entry in the space should benefit HIPH. According to Market Reports Center, the size of the blockchain industry will grow to $60.7 billion by the year 2024. HIPH is looking for more opportunities in the blockchain/crypto space that will complement its existing LALPINATM and Gents brands.

Aggressive marketing push to drive topline

HIPH plans to enter into partnerships and collaborations to increase distribution and marketing reach. The JV with China-based Zhangjiagang Advanced Company and collaborations with Showtime drama 'Billions' and fitness chain SoulCycle should help expand Gents footprint and consumer reach. Further, LALPINA's distribution agreement with GNC, one of the world's largest vendors of health and nutritional products, is likely to result in strong order flow. The management noted that it is working on several more distribution partnerships for both brands which should further bolster the topline.

Initiate coverage with a price target of $0.15

We see HIPH as a high risk and high reward consumer brand play. The target of $0.15 assumes that the company is successful in executing its organic and inorganic growth revolving around product expansion, strategic partnerships and M&A. Key risks include inability to raise capital for its growth initiatives and delay in the launch of LALPINATM Hydrogen CBD.

Please review important disclosures in the report and on our website at www.seethruequity.com.

About American Premium Water Corp.

HIPH is a manufacturer, distributor, and marketer of branded consumer products. It currently markets and distributes products under LALPINATM and Gents brands. Under the LALPINATM brand, the company develops hydrogen-infused energy products. Currently, the product line includes - 1) LALPINATM Hydrogen and 2) LALPINATM Hydrogen CBD. Gents is a producer of luxury hats and other fine accessories and apparel. The brand is carried in over 200 retail outlets internationally, including Bloomingdale's, Nordstrom, and Saks Fifth Avenue, among other boutiques and upscale retailers. For more information, visit www.americanpremiumwater.com

About SeeThruEquity

Since its founding in 2011, SeeThruEquity has been committed to its core mission: providing impactful, high quality research on underfollowed smallcap and microcap equities. SeeThruEquity has pioneered an innovative approach to deliver equity research of microcap and smallcap companies. SeeThruEquity has also been the host of acclaimed investor conferences that are the ultimate event for publicly traded companies with market capitalizations less than $1 billion since 2012.

SeeThruEquity is approved to contribute its research reports and estimates to Thomson One Analytics (First Call), the leading estimates platform on Wall Street, as well as Capital IQ and FactSet. SeeThruEquity maintains one of the industry's most extensive databases of opt-in institutional and high net worth investors. The firm is headquartered in Midtown Manhattan in New York City.

For more information visit www.seethruequity.com.

Contact:

SeeThruEquity
info@seethruequity.com

SOURCE: SeeThruEquity
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Segway Powersports Ventures into Baja 1000: Ambitions Run High

Updated Category News Views 133

They're gunning for glory in the sands of Baja, folks—Segway Powersports is about to rev up the excitement with its Baja 1000 debut. Never heard before in this legendary race's chronicles, Segway aims to shake up the game with their two brawny Super Villain UTVs. These aren't your run-of-the-pavement ride-ons; they're built for the rough stuff—and if there's a stage...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 353

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 189

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 386

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 694

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 234

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 226

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 475

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
UAE Pioneers eATA Carnet System Beyond Europe

Updated Category News Views 139

Breaking Tradition with Digital Innovation Well, who would’ve thought? The UAE just leapt ahead in the trade game, becoming the first to roll out the eATA Carnet system beyond the cozy confines of Europe. This isn’t some run-of-the-mill tech rollout, folks. It’s a digital revolution in how temporary imports are handled—goodbye paper, hello efficiency! With this...

Continue Reading
Nutex Health Scores Top Workplace Honor in 2026

Updated Category News Views 43

Nutex Health: Accolades and Aspirations Nutex Health just snagged something pretty noteworthy: They've been crowned a 2026 Houston Top Workplace by the Houston Chronicle. Now, before you start throwing confetti, let's chew on what this really means. It's no small potatoes, folks. We're talking employee respect and satisfaction measured by Energage’s surveys. It's proof...

Continue Reading

Top 5 Most Recently Viewed Articles

Orla Mining's Earnings Predictions and Market Insights

Updated Category News Views 537

Anticipated Earnings Release for Orla Mining Orla Mining (AMEX: ORLA) is set to unveil its quarterly earnings, and investors are keenly observing the upcoming report. Analysts are projecting the company will announce an earnings per share (EPS) of $0.20, which generates a mix of anticipation and excitement in the market. Insights Into Previous Earnings Performance In the...

Continue Reading
Bar Leone Reigns Supreme as Asia's Best Bar Again

Updated Category News Views 209

Bar Leone Recognized as Asia's Leading Bar for Two Years Bar Leone has once again captured the prestigious title of The Best Bar in Asia, an accolade it earned for the second consecutive year at the Asia's 50 Best Bars ceremony. This recognition, sponsored by Perrier, marks a significant milestone in the vibrant cocktail culture across the continent. Outstanding...

Continue Reading
Commvault Faces Securities Fraud Lawsuit: What's Next?

Updated Category News Views 36

Unpacking Commvault's Legal Headaches There's fresh trouble brewing in the world of Commvault Systems Inc. (NASDAQ: CVLT). Investors licking their wounds have a chance to rally in a securities fraud class action lawsuit. It all circles back to some allegedly shady moves—or, more precisely, what the company didn't spill between April 2025 and January 2026. The Crux of...

Continue Reading
Investigating Lumos Pharma's Acquisition: Implications for Shareholders

Updated Category News Views 76

Investigation into Lumos Pharma's Proposed Acquisition Rowley Law PLLC is currently looking into potential securities law violations related to Lumos Pharma, Inc. (NASDAQ: LUMO). This investigation centers around the proposed acquisition of Lumos Pharma by Double Point Ventures LLC. Under the terms of this acquisition, shareholders are set to receive $4.25 along with one...

Continue Reading
LKQ Faces Investor Suit: Key Impacts & Deadlines

Updated Category News Views 17

LKQ's Acquisition Missteps Ignite Investor Action Just when you think you've seen it all in the stock market, something like this drops—another punch in the gut reminding us that no company is impervious to stumbling. LKQ Corporation (NASDAQ: LKQ) has got itself tangled in some messy legal affairs, thanks to a string of ugly truths coming to light from its pricey $2.1...

Continue Reading